From 33668e8a0164d84b0fa694cc21afc3e0c012d178 Mon Sep 17 00:00:00 2001 From: Will King Date: Fri, 30 Aug 2024 13:05:55 -0700 Subject: [PATCH] another minor edit to intro --- Latex/Paper/sections/01_introduction.tex | 6 ++++++ 1 file changed, 6 insertions(+) diff --git a/Latex/Paper/sections/01_introduction.tex b/Latex/Paper/sections/01_introduction.tex index 24bebe5..9f1a113 100644 --- a/Latex/Paper/sections/01_introduction.tex +++ b/Latex/Paper/sections/01_introduction.tex @@ -13,5 +13,11 @@ These regulations, such as clinical trial standards \todo{add citation to clinic increase the costs of developing new drugs, adding to the business conserns already present, including competitors already in the market or close to entering and the overall demand to address a given condition. +%begin discussing failures +%I am thinking I'll discuss marketing and operational failures +%I somehow need to step away from the drug development framing and soften it to ... what? drug investigation? + +While discovering that a drug doesn't work or is unsafe is a scientific failure, other failure modes occur. +\cite{khmelnitskaya_competitionattritiondrug_2021} explored how to identify business related failures within the drug development pipeline. \end{document}